C-SSRS scoring and risk documentation

The Columbia Suicide Severity Rating Scale (C-SSRS) is the most widely used structured suicide-risk instrument in outpatient behavioral health. It is short, validated across populations, and structured enough that two clinicians scoring the same patient should land nearby. It is also frequently mis-charted: pasted into the HPI as free text, scored without the qualifying questions, or skipped on a stable patient who later has a bad week.

When to administer

Give the C-SSRS where suicide risk is most likely to change or be missed:

• Every new-patient intake. A negative C-SSRS on day one is the reference point for later visits.
• Any visit where the patient endorses item 9 on the PHQ-9 or mentions suicidal thoughts, plans, or behaviors.
• Any visit where the picture changes: new diagnosis, new psychosocial stressor, recent hospitalization, recent self-harm, recent loss.
• Before and after major treatment changes that carry suicide-risk implications: new antidepressant in adolescents, dose escalation, taper of a stabilizing medication, transition from inpatient or partial hospitalization.
• On a routine cadence for high-risk patients in active treatment, even when the picture looks stable. Quarterly is a reasonable default; some practices use every visit.

Do not give it to everyone at every visit. Used that way it becomes noise.

Which version

Three versions are in clinical use:

• Full Lifetime/Recent. The complete instrument, for intake and complex cases.
• Since Last Visit. The follow-up version, focused on what changed.
• Screener. A 6-item short form for triage and high-volume settings.

Pick one per visit type and stay consistent. Most outpatient practices use Lifetime/Recent at intake and Since Last Visit at follow-up, with the Screener reserved for crisis triage or low-acuity primary care.

How to administer

Administer it as an interview, not a paper handout. The qualifying questions (“Have you actually had any thoughts of killing yourself?” before going further) require you to hear the answer and the nuance. Hesitation, a qualifier, or a wording shift is clinical information a Likert form will lose.

Standard order:

1. Wish to be dead (item 1).
2. Non-specific active suicidal thoughts (item 2).
3. Active suicidal ideation with method (item 3).
4. Active suicidal ideation with intent (item 4).
5. Active suicidal ideation with plan and intent (item 5).
6. Behavior in the relevant lookback period (actual attempt, interrupted attempt, aborted attempt, preparatory acts, non-suicidal self-injury).

If item 1 is negative, skip items 2 through 5 per the standard scoring rule. Lethality questions follow if any behavior is endorsed.

Do not change the wording. The validation rests on the wording.

How to score

Two scores come out. The ideation score (1 through 5) is the highest endorsed ideation level. The behavior score is categorical (no behavior, preparatory, aborted, interrupted, attempt) with a lethality rating when an attempt is endorsed.

Common traps:

• A patient who says “I would never act on it” still endorses the underlying ideation. Item 4 (intent) captures that distinction. Score the ideation honestly and let item 4 do its job.
• Non-suicidal self-injury (NSSI) is captured separately. NSSI without suicidal intent is clinically important and chartable. It is not a suicide attempt.
• The lookback window matters. “Since last visit” is shorter than “in the past month” is shorter than “lifetime.” Use the version that matches the window you intend to assess.

How to chart

Put the C-SSRS in structured fields, not a paragraph in the HPI. Same reasons as PHQ-9 and GAD-7, plus one more: when a patient has a bad outcome, the chart will be reviewed. A structured C-SSRS with date, version, item-level responses, and clinician interpretation is far more defensible than “C-SSRS negative” buried in HPI prose.

A complete charted C-SSRS includes:

• Version administered (Lifetime/Recent, Since Last Visit, Screener) and lookback window.
• Item-level responses for items 1 through 5.
• Behavior section: any preparatory, aborted, interrupted, or actual events in the lookback window, with lethality rating where applicable.
• Most recent behavior date if any behavior was ever endorsed (lifetime).
• Clinician interpretation: low, moderate, or high acute risk; low, moderate, or high chronic risk.
• Reasoning that ties the score to the clinical picture.
• The risk-mitigation plan in effect after the visit.

In Nextvisit, the C-SSRS lives in Scales and Exams on the patient profile (/patient/[uuid]/scales) as a structured instrument. Aria captures the conversational portion and routes responses into those fields. The trend shows in the patient header. The risk interpretation belongs in the assessment as prose as well.

If your system does not support a structured C-SSRS, use a dedicated EHR-template section with a consistent format. Free text in the HPI is the worst option for this scale.

Risk interpretation: the part that matters

The clinician determines the risk level from the C-SSRS score and the clinical context.

A defensible interpretation looks like this:

Acute suicide risk assessed as moderate. Patient endorses ideation at item 3 level (suicidal thoughts with method, no intent or plan) in the past week, in the context of recent job loss and disrupted sleep. No behavior endorsed in the lookback window. Chronic risk assessed as moderate based on prior attempt in 2023, sustained depressive episode this year, and limited social supports. Protective factors include engaged treatment, stable housing, and access to family. Plan addresses access to means, increased visit frequency, and crisis-line review with the patient.

Reviewers and auditors are looking for the reasoning, not the number.

What “low acute risk” should not look like

“Patient denies SI/HI. Low risk.” on every chart, regardless of context, is templated documentation. If the patient just disclosed a divorce and the assessment matches the prior six visits, the chart will not hold up. Even on a stable patient, “no SI endorsed today; risk remains low in the context of stable medication, engaged treatment, and intact supports” is closer to defensible than the boilerplate.

When the assessment changes the plan

• Low acute, low chronic: routine follow-up, standard safety planning if any history.
• Moderate acute, low to moderate chronic: increased visit frequency, means restriction, written safety plan, family or support involvement where appropriate.
• High acute or imminent risk: do not let the patient leave without a higher level of care. Document the disposition (ED transfer, voluntary admission, mobile crisis, partial hospitalization) and the handoff.

“Follow up in 2 weeks” is not a plan after a moderate-acute assessment. “Follow up in 1 week, crisis line reviewed, partner aware of the elevated risk and lock box obtained for medications, return precautions discussed” is.

In Nextvisit, the C-SSRS is a structured scale on the patient profile. Aria lands the responses. Your interpretation belongs in the assessment. The trend is on the timeline.